Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
Group One Trading's PRAX Position: Q3 2026 in Review
Group One Trading reduced its Praxis Precision Medicines (PRAX) stake by 15% in Q3 2026, selling an estimated $82.4K and leaving 1,417 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #3582.
Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 15 quarters since. The position peaked at $3.5M in Q3 2024. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Group One Trading held 1,417 shares of Praxis Precision Medicines worth $413K as of Q3 2026.
- Group One Trading sold 249 Praxis Precision Medicines shares in Q3 2026, an estimated $82.4K.
- Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #3582 holding.
- Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 15 quarters since.
- Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
- 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.